Figure 2.
Kaplan-Meier plot of progression-free survival (PFS) in the GANNET53 Phase I trial. All 10 patients included experienced disease progression (no censored cases).
Kaplan-Meier plot of progression-free survival (PFS) in the GANNET53 Phase I trial. All 10 patients included experienced disease progression (no censored cases).